Corporate News Report – Synbiotic (SBX.DE)
SynBiotic SE, a German cannabis‑focused company listed on Xetra, announced its intention to file for insolvency with the Münster court. The company had previously sought additional funding, but the attempts failed and no new capital measures were approved. The insolvency announcement caused the share price to fall sharply, with the stock trading at approximately EUR 0.17 per share on Tuesday, 20 October 2026. The final outcome of the insolvency proceedings remains undetermined, leaving shareholder prospects uncertain.
Current Market Snapshot
| Item | Value |
|---|---|
| Last 24‑hour price change | –23.81 % |
| Current price (05:30 PM CET, Tue 20 Oct) | EUR 0.17 |
| Shares outstanding | 7.5 million |
| Market capitalization | EUR 1.4 million |
| 24‑hour traded volume | EUR 21 000 |
| Price 30‑days ago | –81.61 % relative to last month‑end |
| 200‑day simple moving average | EUR 1.61 |
| 52‑week high | EUR 3.84 (17 Dec 2025) |
| 52‑week low | EUR 0.11 (19 Oct 2026) |
Comparative Performance – Past 24 Hours
| Stock | Exchange | 24‑hour change | Current price | Market cap | P/E ratio |
|---|---|---|---|---|---|
| Cr Energy (CRZK.F) | Xetra | 0 % | EUR 0.06 | EUR 1.5 million | 0.14 |
| Valora Effekten Handel (VEH.SG) | Xetra | 0 % | EUR 0.70 | EUR 1.2 million | 28.53 |
| Planethic (VEZ.F) | Xetra | –4.45 % | EUR 0.65 | EUR 1.6 million | 0.06 |
| Cannovum Cannabis (27N0.DE) | Xetra | –3.11 % | EUR 0.45 | EUR 1.1 million | — |
Company Profile
- Name: SynBiotic SE
- Headquarters: Munich, Germany
- Primary Sector: Medical cannabis (Germany)
- Other Sectors: Healthcare, pet, beauty, eCommerce, hospitality, and related German industries
- Website: www.synbiotic.com
- Exchange: Xetra (ticker SBX.DE)
Conclusion
SynBiotic SE’s filing for insolvency has led to a significant decline in its share price, with current valuations hovering well below the 200‑day moving average and historical highs. The company’s future depends on the outcome of the insolvency proceedings, and stakeholders should monitor court decisions closely for further developments.
